Literature DB >> 30798542

Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.

Edgar X Sherman1,2,3,4, Jessie E Wozniak1,2,3,4, David S Weiss5,6,7,8.   

Abstract

The nosocomial pathogen Acinetobacter baumannii is a growing threat to public health due to its increasing resistance to antibiotics including the last-line polymyxin, colistin. Heteroresistance to colistin has been described in A. baumannii, wherein a resistant subpopulation of cells coexisting with a majority susceptible subpopulation actively grows in the presence of antibiotic and can cause treatment failure. The shortcomings of diagnostic tests in detecting colistin heteroresistance are especially worrisome as they may lead to clinicians unknowingly prescribing an ineffective antibiotic, leading to increased patient morbidity and mortality.Several techniques can be used to detect heteroresistance, and the purpose of this chapter is to outline effective methods for identifying, quantifying, and analyzing heteroresistance to colistin in A. baumannii. We will highlight the advantages and disadvantages of techniques including population analysis profile (PAP), Etest, and disc diffusion, as well as additional methods to distinguish heteroresistance from other forms of resistance. While the scope of this chapter will focus on colistin heteroresistance in A. baumannii, these techniques can be adapted for the study of heteroresistance to other antibiotics and in other bacteria with slight modifications.

Entities:  

Keywords:  Antibiotic susceptibility testing; Colistin; Heteroresistance; Phenotypic antibiotic resistance; Polymyxin; Population analysis profile; Resistant subpopulations

Mesh:

Substances:

Year:  2019        PMID: 30798542      PMCID: PMC6637766          DOI: 10.1007/978-1-4939-9118-1_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.

Authors:  Joshua S Hawley; Clinton K Murray; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

3.  Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.

Authors:  E Matuschek; D F J Brown; G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2013-10-17       Impact factor: 8.067

4.  Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.

Authors:  Sarah W Satola; Monica M Farley; Karen F Anderson; Jean B Patel
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

5.  Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.

Authors:  Wing Yau; Roxanne J Owen; Anima Poudyal; Jan M Bell; John D Turnidge; Heidi H Yu; Roger L Nation; Jian Li
Journal:  J Infect       Date:  2008-12-06       Impact factor: 6.072

Review 6.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

7.  Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.

Authors:  Carlos Hernan Rodriguez; Rodriguez Carlos Hernan; Karina Bombicino; Bombicino Karina; Gabriela Granados; Granados Gabriela; Marcela Nastro; Nastro Marcela; Carlos Vay; Vay Carlos; Angela Famiglietti; Famiglietti Angela
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

Review 8.  Acinetobacter baumannii: evolution of a global pathogen.

Authors:  Luísa C S Antunes; Paolo Visca; Kevin J Towner
Journal:  Pathog Dis       Date:  2014-01-27       Impact factor: 3.166

9.  Molecular mechanisms underlying bacterial persisters.

Authors:  Etienne Maisonneuve; Kenn Gerdes
Journal:  Cell       Date:  2014-04-24       Impact factor: 66.850

10.  MODE OF ACTION OF STREPTOMYCIN ON TYPE b HEMOPHILUS INFLUENZAE : II. NATURE OF RESISTANT VARIANTS.

Authors:  H E Alexander; G Leidy
Journal:  J Exp Med       Date:  1947-05-31       Impact factor: 14.307

View more
  9 in total

1.  A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.

Authors:  Shawn M Zimmerman; Audrey-Ann J Lafontaine; Carmen M Herrera; Amanda B Mclean; M Stephen Trent
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance Mechanism.

Authors:  Arturo Martínez-Trejo; Juan Manuel Ruiz-Ruiz; Luis Uriel Gonzalez-Avila; Andrés Saldaña-Padilla; Cecilia Hernández-Cortez; Miguel Angel Loyola-Cruz; Juan Manuel Bello-López; Graciela Castro-Escarpulli
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

3.  R93P Substitution in the PmrB HAMP Domain Contributes to Colistin Heteroresistance in Escherichia coli Isolates from Swine.

Authors:  Qihong Kuang; Dandan He; Huarun Sun; Huihui Hu; Fulin Li; Wenya Li; Gongzheng Hu; Hua Wu; Li Yuan
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

4.  Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital.

Authors:  Khin Thet Thet; Kamonwan Lunha; Arpasiri Srisrattakarn; Aroonlug Lulitanond; Ratree Tavichakorntrakool; Waewta Kuwatjanakul; Nicha Charoensri; Aroonwadee Chanawong
Journal:  World J Microbiol Biotechnol       Date:  2020-07-01       Impact factor: 3.312

5.  Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?

Authors:  Federica Sacco; Paolo Visca; Federica Runci; Guido Antonelli; Giammarco Raponi
Journal:  Antibiotics (Basel)       Date:  2021-01-05

6.  Emergence of polymyxin B-heteroresistant hypervirulent Klebsiella pneumoniae from an individual in the community with asymptomatic bacteriuria.

Authors:  Jun Li; Mengli Tang; Fengjun Xia; Changhang Min; Yongmei Hu; Haichen Wang; Mingxiang Zou
Journal:  BMC Microbiol       Date:  2022-02-07       Impact factor: 3.605

7.  Quantitative Pharmacodynamic Characterization of Resistance versus Heteroresistance of Colistin in E. coli Using a Semimechanistic Modeling of Killing Curves.

Authors:  Andrew Mead; Pierre-Louis Toutain; Pascal Richez; Ludovic Pelligand
Journal:  Antimicrob Agents Chemother       Date:  2022-08-30       Impact factor: 5.938

8.  Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan.

Authors:  Noor Andryan Ilsan; Yuarn-Jang Lee; Shu-Chen Kuo; I-Hui Lee; Tzu-Wen Huang
Journal:  Microorganisms       Date:  2021-06-14

9.  Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates.

Authors:  Hadas Kon; Amichay Hameir; Elizabeth Temkin; Alona Keren-Paz; David Schwartz; Vered Schechner; Yehuda Carmeli
Journal:  Microorganisms       Date:  2021-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.